Iceland· IS-711396

Sendoxan

A cyclophosphamide product containing cyclophosphamidum inn, registered in Iceland by Baxter Medical AB*. The same ATC class is registered in 17 of our 19 countries.

ATC L01AA01

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedSendoxanATCL01AA01REGISTER NO.IS-711396PACKS LISTED2CHECKEDSeptember 29, 2026

Where it is registered

Cyclophosphamide is registered in 17 of 19 countries.

Countries holding a registration under ATC L01AA01 (cyclophosphamide), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 10 of them publish a price we can compare per daily dose

Cyclophosphamide · ATC L01AA01

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cyclophosphamide costs, country by country.

Normalised to the WHO defined daily dose (0.25 g), the median price runs from $1.57 in France to $14.12 in Switzerland — a ×9.0 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Cyclophosphamide · price per daily dose (0.25 g)

USD · FX 28 Sept 2026

  • CH Switzerland$14.12
  • IT Italy$1.58
  • FR France$1.57
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Cyclophosphamidum INN
Manufacturer
Baxter Medical AB*
Country
Iceland (IS)
ATC code
L01AA01
ATC class
Cyclophosphamide
Defined daily dose
0.25 g, P
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 2

2 priced
  • ean
    433089
    1 stk x1 hgl
    ISK 7102
  • ean
    118658
    1 stk x1 hgl
    ISK 7102

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

541 interactions on record for cyclophosphamide.

Graded by severity as the source publishes them — 34 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cyclophosphamide · interactions on record

541 records

  • 34 severe
  • 172 moderate
  • 29 minor
  • 304 info

Most severe, free to view

  • Nalidixic acidJ01MB02severe
  • CidofovirJ05AB12severe
  • ThiotepaL01AC01severe
  • CladribineL01BB04severe

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cyclophosphamide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cyclophosphamide products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Cyclophosphamid Sandoz, Endoxan
  • Belgium · Cyclofosfamide Accord, Cyclophosphamide Hikma
  • Bulgaria · Cyclophosphamide Sandoz, Ендоксан
  • Cyprus · Cyclophosphamide Accord, Endoxan
  • Czechia · Cyclophosphamide Accord, Endoxan
  • Germany · Cyclophosphamid Accord, Cyclophosphamid Beta
  • Denmark · Cyclophosphamide Accord, Cyclophosphamide Sandoz
  • Estonia · Cyclophosphamide Accord, Endoxan
  • Spain · Ciclofosfamida Accord, Ciclofosfamida Dr. Reddy
  • Finland · Cyclophosphamide Accord, Sendoxan
  • France · Cyclophosphamide Accord, Cyclophosphamide Reddy Pharma
  • United Kingdom (Northern Ireland) · Cyclophosphamide Accord Healthcare, Cyclophosphamide Accord-Uk
  • Greece · Endoxan
  • Croatia · Ciklofosfamid Accord, Endoxan
  • Hungary · Endoxan
  • Ireland · Cyclophosphamide Monohydrate Seacross, Endoxana
  • Italy · Ciclofosfamide Accord, Cyclophosphamide Monohydrate Seacross
  • Lithuania · Cyclophosphamide Accord Healthcare, Endoxan
  • Luxembourg · Endoxan
  • Latvia · Cyclophosphamide Accord, Endoxan
  • Malta · Endoxana, Endoxana Injection
  • Netherlands · Cyclofosfamide Accord, Cyclofosfamide Hikma
  • Norway · Cyclophosphamide Accord, Sendoxan
  • Poland · Cyclophosphamide Accord, Cyclophosphamide Sandoz
  • Portugal · Ciclofosfamida Accord, Ciclofosfamida Hikma
  • Romania · Ciclofosfamidă Accord, Ciclofosfamidă Dr. Reddy’s
  • Sweden · Cyclophosphamide Accord, Cyclophosphamide Sandoz
  • Slovenia · Endoxan
  • Slovakia · Endoxan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/462dca8a-dfa7-4320-b9e5-cf4f359a4c2f
GET /v1/drugs/462dca8a-dfa7-4320-b9e5-cf4f359a4c2f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Stungulyfs-/innrennslisstofn, lausn",
  "source": "lyfjastofnun",
  "atc_raw": "L01AA01",
  "marketed": true,
  "strength": "500 mg",
  "ma_number": "711396",
  "substance": "Cyclophosphamidum INN",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
  "ma_issued_serial": "26038"
}

See everything about cyclophosphamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.